Melgama

Benfotiamine, the active ingredient in Melgama, is a thiamine derivative (vitamin B1 analogue) presented as an oral supplement for oral use. It supports normal glucose metabolism and is used as adjunctive support in diabetic neuropathy and to prevent thiamine deficiency.

GNH USA supplies Melgama as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality manufacturing and regulatory compliance across global markets. The company adheres to stringent quality standards and provides reliable supply chain solutions for healthcare providers.

Benfotiamine acts on carbohydrate metabolism and oxidative stress pathways, making it useful in several metabolic and neuropathic conditions.

- Normal glucose metabolism: helps maintain carbohydrate processing in individuals with elevated blood sugar. - Diabetic neuropathy: provides adjunctive support to alleviate nerve‑related symptoms in diabetes. - Thiamine deficiency prevention: supplies bioavailable vitamin B1 to individuals at risk of deficiency.

Benfotiamine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Gastrointestinal upset: mild nausea or abdominal discomfort. - Headache: transient mild to moderate headache. - Skin rash: occasional mild erythema or pruritus. - Dizziness: occasional light‑headed sensation.

Serious or Rare Side Effects: - Hypersensitivity reactions: including anaphylaxis or severe skin eruptions. - Hepatic enzyme elevation: rare increases in liver function tests. - Hematologic abnormalities: very rare reports of blood count changes.

When using Benfotiamine, consider the following precautions.

- Assess renal function: adjust use in severe renal impairment. - Monitor blood glucose: observe for unexpected changes in glycemic control. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Pregnancy and lactation: use only if potential benefits outweigh risks. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Benfotiamine may interact with other medicines; monitor as indicated.

Major Interactions (Avoid): - High‑dose thiamine supplements: risk of excessive thiamine levels. - Certain chemotherapeutic agents (e.g., 5‑fluorouracil): potential antagonistic effect.

Moderate Interactions (Monitor Closely): - Antidiabetic drugs: may enhance glucose‑lowering effect, requiring dose adjustment. - Statins: monitor for muscle‑related symptoms. - Alcohol consumption: may increase thiamine requirement and affect efficacy.